O. Reman

A. Vekhoff, M. Labopin, M. Mohty, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Rituximab salvage therapy in adults with immune thrombocytopenia: retrospective study on efficacy and safety profiles

M. Macro, X. Troussard, O. Reman, 2016, International Journal of Hematology.

Clinical relevance of gallium-67 scintigraphy in lymphoma before and after therapy

M. Macro, S. Bardet, O. Reman, 2000, European Journal of Nuclear Medicine.

[Place of celio-video-surgery in splenectomy for hematologic diseases].

O. Reman, M. Leporrier, G. Samama, 1995, Annales de chirurgie.

Is pegfilgrastim safe and effective in congenital neutropenia? An analysis of the French Severe Chronic Neutropenia registry

F. Jardin, T. Leblanc, Y. Bertrand, 2009, Pediatric blood & cancer.

Full Response of a Localized Renal Tumour after Reduced-Intensity Conditioned Hematopoietic Stem Cell Transplantation

O. Reman, M. Leporrier, A. Gac, 2009, Case reports in medicine.

Brief Report Results and Discussion

H. Dombret, C. Bastard, C. Preudhomme, 2022 .

Two distinct truncated variants of ankyrin associated with hereditary spherocytosis

S. Hayette, O. Reman, P. Maillet, 1998, American journal of hematology.

The prognostic value of hematogones in patients with acute myeloid leukemia

M. Macro, O. Reman, J. Parienti, 2016, American journal of hematology.

Comparison of high-dose cytarabine and timed-sequential chemotherapy as consolidation for younger adults with AML in first remission: the ALFA-9802 study.

J. Bourhis, H. Dombret, B. Quesnel, 2011, Blood.

Hematogones: a new prognostic factor for acute myeloblastic leukemia.

M. Macro, V. Salaün, O. Reman, 2011, Blood.

High-dose imatinib mesylate combined with vincristine and dexamethasone (DIV regimen) as induction therapy in patients with resistant Philadelphia-positive acute lymphoblastic leukemia and lymphoid blast crisis of chronic myeloid leukemia

H. Dombret, X. Thomas, C. Récher, 2006, Leukemia.

Interim Analysis of the Randomized Eortc/Lysa/Fil Intergroup H10 Trial On Early PET-Scan Driven Treatment Adaptation in Stage I/II Hodgkin Lymphoma

J. Raemaekers, M. Federico, C. Sebban, 2012 .

Long-term follow-up of an age-adapted C5R protocol followed by radiotherapy in 99 newly diagnosed primary CNS lymphomas: a prospective multicentric phase II study of the Groupe d'Etude des Lymphomes de l'Adulte (GELA).

J. Blay, B. Coiffier, O. Casasnovas, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Autologous or allogeneic stem cell transplantation as post-remission therapy in refractory or relapsed acute myeloid leukemia after highly intensive chemotherapy

H. Dombret, A. Vekhoff, P. Fenaux, 2005, Leukemia & lymphoma.

Autologous Stem Cell Transplantation in Acute Promyelocytic Leukemia Patients Achieving a Second Complete Remission

H. Dombret, A. Vekhoff, P. Fenaux, 2000 .

Azacytidine in refractory or relapsed AML after intensive chemotherapy (IC): results of the French ATU Program

A. Stamatoullas, B. Quesnel, E. Wattel, 2010 .

Dasatinib (Sprycel®) and Low Intensity Chemotherapy for First-Line Treatment In Elderly Patients with De Novo Philadelphia Positive ALL (EWALL-PH-01): Kinetic of Response, Resistance and Prognostic Significance

J. Cayuela, H. Dombret, A. Delannoy, 2010 .

Sequential regimen of clofarabine, cytosine arabinoside and reduced-intensity conditioned transplantation for primary refractory acute myeloid leukemia

M. Labopin, P. Chevallier, I. Yakoub-Agha, 2017, Haematologica.

Outcome of treatment after first relapse in younger adults with acute myeloid leukemia initially treated by the ALFA-9802 trial.

J. Bourhis, H. Dombret, B. Quesnel, 2012, Leukemia research.

Treatment of adult ALL with central nervous system involvement at diagnosis using autologous and allogeneic transplantation: a study from the Société Française de Greffe de Moelle et de Thérapie Cellulaire

M. Robin, M. Mohty, E. Deconinck, 2013, Bone Marrow Transplantation.

Epigenetic Therapy with 5-Azacitidine, Valproic Acid, and ATRA in Patients with High-Risk AML or MDS: Results of the French VIVEDEP Phase II Study

H. Dombret, C. Gardin, C. Récher, 2008 .

When can real-time quantitative RT-PCR effectively define molecular relapse in acute promyelocytic leukemia patients? (Results of the French Belgian Swiss APL Group).

H. Dombret, A. Baruchel, S. Chevret, 2009, Leukemia research.

Allogeneic stem cell transplantation (allo-SCT) for de novo Ph+ AML: a study from the French Society of Bone Marrow Transplantation and Cell Therapy

I. Yakoub-Agha, D. Blaise, M. Mohty, 2015, Bone Marrow Transplantation.

Fractionated Doses of Gemtuzumab Ozogamicin (GO) Combined to Standard Chemotherapy (CT) Improve Event-Free and Overall Survival in Newly-Diagnosed De Novo AML Patients Aged 50–70 Years Old: A Prospective Randomized Phase 3 Trial From the Acute Leukemia French Association (ALFA)

H. Dombret, S. Chevret, C. Preudhomme, 2011 .

Randomized Comparison of Standard Induction with Daunorubicin (DNR) for 3 Days vs Idarubicin (IDA) for 3 or 4 Days in AML pts Aged 50 to 70 and of Maintenance with Interleukin 2. Final Analysis of the ALFA 9801 Study.

J. Bourhis, H. Dombret, S. Chevret, 2007 .

IgE multiple myeloma.

F. Chapon, M. Macro, X. Troussard, 1999, Leukemia & lymphoma.

Pure red-cell aplasia with fludarabine for chronic lymphocytic leukaemia

X. Troussard, O. Reman, M. Leporrier, 1993, The Lancet.

Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial.

J. Raemaekers, R. Bouabdallah, A. Stamatoullas, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Flow cytometry minimal residual disease after allogeneic transplant for chronic lymphocytic leukemia

J. Golmard, M. Béné, A. Plesa, 2017, European journal of haematology.

Primary CNS lymphoma at first relapse/progression: characteristics, management, and outcome of 256 patients from the French LOC network.

R. Houot, F. Jardin, K. Hoang-Xuan, 2016, Neuro-oncology.

Lymphomatoid Granulomatosis Treated Successfully with Rituximab in a Renal Transplant Patient

F. Chapon, O. Reman, B. Hurault de Ligny, 2011, Journal of transplantation.

Outcome Of Patients With IPSS Intermediate (int) Or High Risk Myelodysplastic Syndrome (MDS) According To Donor Availability: A Multicenter Prospective Non Interventional Study For The SFGM-TC and GFM

R. Porcher, H. Dombret, P. Fenaux, 2013 .

Hemibody irradiation in stage III multiple myeloma: results of 20 patients.

M. Macro, X. Troussard, O. Reman, 1988, Nouvelle revue francaise d'hematologie.

Chronic myeloid leukemia in first chronic phase not responding to α-interferon: outcome and prognostic factors after autologous transplantation

G. Meloni, J. Reiffers, C. Carlo-Stella, 1999, Bone Marrow Transplantation.

Which AML Subsets Benefit from Leukemic Cell Priming during Chemotherapy? Long-Term Analysis of the ALFA-9802 GM-CSF Study

J. Bourhis, H. Dombret, C. Preudhomme, 2008 .

Transfusion strategy in hematological intensive care unit: study protocol for a randomized controlled trial

F. Jardin, B. Dervaux, L. Guittet, 2015, Trials.

Baseline total metabolic volume (TMTV) to predict the outcome of patients with advanced Hodgkin lymphoma (HL) enrolled in the AHL2011 LYSA trial.

G. Salles, R. Bouabdallah, A. Stamatoullas, 2016 .

Clofarabine-Based Consolidation Improves Relapse-Free Survival of Younger Adults with Non-Favorable Acute Myeloid Leukemia (AML) in First Remission: Results of the Randomized ALFA-0702/Clara Study (NCT 00932412)

H. Dombret, S. Chevret, C. Preudhomme, 2015 .

Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy.

K. Döhner, R. Schlenk, H. Döhner, 2014, Blood.

Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study

H. Dombret, S. Chevret, C. Preudhomme, 2012, The Lancet.

Randomized study of intensified anthracycline doses for induction and recombinant interleukin-2 for maintenance in patients with acute myeloid leukemia age 50 to 70 years: results of the ALFA-9801 study.

J. Bourhis, H. Dombret, S. Chevret, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Sweet Syndrome Associated with Acute Myelogenous Leukemia

X. Troussard, O. Reman, F. Jacobs, 1991, International journal of dermatology.

Multicenter Outbreak of Infections by Saprochaete clavata, an Unrecognized Opportunistic Fungal Pathogen

F. Jardin, C. Ravel, H. Lanic, 2014, mBio.

Infectious complications in adult acute myeloid leukemia: analysis of the Acute Leukemia French Association-9802 prospective multicenter clinical trial

H. Dombret, B. Quesnel, P. Fenaux, 2012, Leukemia & lymphoma.

Virus recovery from stools of patients undergoing bone marrow transplantation.

X. Troussard, J. Ballet, O. Reman, 1993, Bone marrow transplantation.

A Phase 2 study of L‐asparaginase encapsulated in erythrocytes in elderly patients with Philadelphia chromosome negative acute lymphoblastic leukemia: The GRASPALL/GRAALL‐SA2‐2008 study

H. Dombret, S. Leprêtre, P. Chevallier, 2015, American journal of hematology.

Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association

H. Dombret, C. Preudhomme, P. Fenaux, 2011, Leukemia.

Prognostic impact of isocitrate dehydrogenase enzyme isoforms 1 and 2 mutations in acute myeloid leukemia: a study by the Acute Leukemia French Association group.

H. Dombret, B. Quesnel, C. Preudhomme, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Wilms' tumor 1 single-nucleotide polymorphism rs16754 does not predict clinical outcome in adult acute myeloid leukemia

X Thomas, H. Dombret, C. Preudhomme, 2011, Leukemia.

Incidence, Clinical Features, and Outcome of AllTrans-Retinoic Acid Syndrome in 413 Cases of Newly Diagnosed Acute Promyelocytic Leukemia

J. Miguel, H. Dombret, C. Chastang, 1998 .

Incidence, clinical features, and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. The European APL Group.

J. Miguel, H. Dombret, C. Chastang, 1998, Blood.

HLA-matched allogeneic stem cell transplantation improves outcome of higher risk myelodysplastic syndrome A prospective study on behalf of SFGM-TC and GFM

R. Porcher, H. Dombret, M. Robin, 2015, Leukemia.

Pediatric-inspired intensified therapy of adult T-ALL reveals the favorable outcome of NOTCH1/FBXW7 mutations, but not of low ERG/BAALC expression: a GRAALL study.

H. Dombret, E. Macintyre, S. Leprêtre, 2011, Blood.

Cerebral venous thrombosis in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma during induction chemotherapy with l‐asparaginase: The GRAALL experience

H. Dombret, P. Chevallier, X. Thomas, 2015, American journal of hematology.

lymphoblastic leukemia: a LALA-94 study Impact of TCR status and genotype on outcome in adult T-cell acute

J. Cayuela, H. Dombret, E. Macintyre, 2013 .

Impact of TCR status and genotype on outcome in adult T-cell acute lymphoblastic leukemia: a LALA-94 study.

J. Cayuela, H. Dombret, E. Macintyre, 2005, Blood.

Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trial

H. Dombret, A. Stamatoullas, A. Delannoy, 2007, Leukemia.

Role of allogeneic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemia.

J. Bourhis, H. Dombret, P. Chevallier, 2015, Blood.

Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia.

J. Cayuela, H. Dombret, E. Macintyre, 2014, Blood.

Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial.

H. Dombret, A. Stamatoullas, A. Delannoy, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Late psychosocial sequelae in Hodgkin's disease survivors: a French population-based case-control study.

P. Arveux, X. Troussard, F. Joly, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis and/or at first relapse: results from the GET-LALA group.

H. Dombret, A. Stamatoullas, A. Delannoy, 2007, Leukemia research.

Rescue therapy combining intermediate-dose cytarabine with amsacrine and etoposide in relapsed adult acute lymphoblastic leukemia.

A. Stamatoullas, A. Delannoy, C. Gardin, 2004, The Hematology Journal.

Autologous stem cell transplantation in adults with acute lymphoblastic leukemia in first complete remission: analysis of the LALA-85, -87 and -94 trials

H. Dombret, A. Delannoy, J. Gabert, 2006, Leukemia.

Adult T‐biphenotypic acute leukaemia: clinical and biological features and outcome

X. Thomas, O. Reman, C. Boucheix, 2003, British journal of haematology.

Autologous and allogeneic stem-cell transplantation as salvage treatment of acute promyelocytic leukemia initially treated with all-trans-retinoic acid: a retrospective analysis of the European acute promyelocytic leukemia group.

J. Bourhis, H. Dombret, S. Chevret, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intensive salvage therapy with high-dose chemotherapy for patients with advanced Hodgkin's disease in relapse or failure after initial chemotherapy: results of the Groupe d'Etudes des Lymphomes de l'Adulte H89 Trial.

G. Salles, F. Berger, A. Stamatoullas, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation

H. Dombret, A. Stamatoullas, A. Vekhoff, 2000, Leukemia.

Analysis of a French cohort of patients with large granular lymphocyte leukemia: a report on 229 cases

T. Fest, O. Reman, J. Rey, 2010, Haematologica.

[Vaccination post hematopoietic stem cell transplantation: which vaccines and when and, how to vaccinate? An SFGM-TC report].

I. Yakoub-Agha, O. Reman, F. Suarez, 2013, Pathologie-biologie.

Evolving strategies with immunomodulating drugs and tandem autologous/allogeneic hematopoietic stem cell transplantation in first line high risk multiple myeloma patients.

D. Blaise, M. Mohty, P. Moreau, 2013, Experimental hematology.

Budesonide/Formoterol for bronchiolitis obliterans after hematopoietic stem cell transplantation.

S. Chevret, M. Robin, E. Bergot, 2015, American journal of respiratory and critical care medicine.

Impact of Thymoglobulin by Stem Cell Source (Peripheral Blood Stem Cell or Bone Marrow) After Myeloablative Stem Cell Transplantation From HLA 10/10-Matched Unrelated Donors: A Report From the Société Française de Greffe de Moelle et de Thérapie Cellulaire

P. Chevallier, M. Mohty, J. Cassuto, 2016, Transplantation.

Allogeneic stem cell transplantation improves the outcome of adults with t(1;19)/E2A-PBX1 and t(4;11)/MLL-AF4 positive B-cell acute lymphoblastic leukemia: results of the prospective multicenter LALA-94 study

H. Dombret, A. Delannoy, J. Gabert, 2006, Leukemia.

Evaluation of allogeneic hematopoietic SCT in younger adults with adverse karyotype AML

H. Dombret, C. Preudhomme, P. Fenaux, 2012, Bone Marrow Transplantation.

Outcome of acute promyelocytic leukemia treated with all trans retinoic acid and chemotherapy in elderly patients: the European group experience

J. Miguel, J. Bourhis, H. Dombret, 2005, Leukemia.

[Intravascular large B-cell lymphoma].

O. Reman, L. Verneuil, A. Baldolli, 2013, Annales de dermatologie et de venereologie.

Quality of life after successful treatment of early-stage Hodgkin's lymphoma: 10-year follow-up of the EORTC-GELA H8 randomised controlled trial.

M. Kersten, A. Hagenbeek, G. Salles, 2009, The Lancet. Oncology.

Feasibility of the fludarabine busulfan 3 days and ATG 2 days reduced toxicity conditioning in 51 allogeneic hematopoietic stem cell transplantation: a single-center experience.

O. Reman, A. Gac, S. Chantepie, 2014, Leukemia research.

Prior treatment with alpha interferon does not adversely  affect the outcome of allogeneic transplantation  for chronic myeloid leukaemia

J. Reiffers, O. Reman, N. Ifrah, 2002, British journal of haematology.

[Primary adrenal lymphoma. Report of a case].

X. Troussard, O. Reman, Y. Reznik, 1994, Presse medicale.

Increased frequencies of circulating and tumor-resident Vδ1+ T cells in patients with diffuse large B-cell lymphoma

M. Macro, X. Troussard, O. Reman, 2018, Leukemia & lymphoma.

A randomized study of pegylated liposomal doxorubicin versus continuous-infusion doxorubicin in elderly patients with acute lymphoblastic leukemia: the GRAALL-SA1 study

Philippe Rousselot, H. Dombret, A. Delannoy, 2011, Haematologica.

Allogeneic stem cell transplantation for patients with mantle cell lymphoma who failed autologous stem cell transplantation: a national survey of the SFGM-TC

H. Tilly, P. Chevallier, D. Blaise, 2016, Bone Marrow Transplantation.

Double hemibody irradiation with GM-CSF as salvage therapy for refractory chronic lymphocytic leukemia.

X. Troussard, O. Reman, M. Leporrier, 1994, Leukemia & lymphoma.

Postremission treatment of elderly patients with acute myeloid leukemia in first complete remission after intensive induction chemotherapy: results of the multicenter randomized Acute Leukemia French Association (ALFA) 9803 trial.

J. Bourhis, H. Dombret, C. Preudhomme, 2007, Blood.

Effect of Priming with Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Younger Adults with Newly Diagnosed Acute Myeloid Leukemia (AML): A Trial by the Acute Leukemia French Association (ALFA) Group.

J. Bourhis, H. Dombret, B. Quesnel, 2005 .

Randomized Phase II Study of Clofarabine-Based Consolidation for Younger Adults With Acute Myeloid Leukemia in First Remission.

H. Dombret, S. Chevret, C. Preudhomme, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Analysis of prognostic factors after the first relapse of Hodgkin's disease in 187 patients

É. Lepage, O. Reman, J. Gabarre, 1996, Cancer.

[Neutrophilic leukemia and multiple myeloma. 2 cases].

M. Macro, X. Troussard, O. Reman, 1992, Annales de medecine interne.

Chronic myeloid leukemia in first chronic phase not responding to alpha-interferon: outcome and prognostic factors after autologous transplantation. EBMT Working Party on Chronic Leukemias.

G. Meloni, J. Reiffers, C. Carlo-Stella, 1999, Bone marrow transplantation.

Early onset of chemotherapy can reduce the incidence of ATRA syndrome in newly diagnosed acute promyelocytic leukemia (APL) with low white blood cell counts: results from APL 93 trial

J. Miguel, H. Dombret, A. Vekhoff, 2003, Leukemia.

Hierarchical Evaluation of Baseline Poor-Prognosis Factors and Response to Initial Therapy in Younger Adults with Ph-Negative Acute Lymphoblastic Leukemia (ALL) Treated in the Risk-Adapted GRAALL-2003 Study.

H. Dombret, E. Macintyre, A. Delannoy, 2005 .

Efficacy of granulocyte and granulocyte-macrophage colony-stimulating factors in the induction treatment of adult acute lymphoblastic leukemia: a multicenter randomized study.

C. Gardin, X. Thomas, O. Boulat, 2004, The hematology journal : the official journal of the European Haematology Association.

Low dose Rituximab for pre-emptive treatment of Epstein Barr virus reactivation after allogenic hematopoietic stem cell transplantation.

O. Reman, G. Damaj, A. Gac, 2019, Current research in translational medicine.

Towards a Pediatric Approach in Adults with Acute Lymphoblastic Leukemia (ALL): The GRAALL-2003 Study.

H. Dombret, E. Macintyre, A. Delannoy, 2006 .

Dasatinib (Sprycel®) and Chemotherapy for First-Line Treatment in Elderly Patients with De Novo Philadelphia Positive ALL: Results of the First 22 Patients Included in the EWALL-Ph-01 Trial (on Behalf of the European Working Group on Adult ALL (EWALL))

J. Cayuela, H. Dombret, A. Delannoy, 2008 .

NOTCH1/FBXW7 Mutation Identifies a Large Subgroup with Favorable Outcome in Adult T-ALL: A GRAALL Study.

H. Dombret, E. Macintyre, M. Béné, 2008 .

ABVD or BEACOPPbaseline along with involved-field radiotherapy in early-stage Hodgkin Lymphoma with risk factors: Results of the European Organisation for Research and Treatment of Cancer (EORTC)-Groupe d'Étude des Lymphomes de l'Adulte (GELA) H9-U intergroup randomised trial.

J. Raemaekers, G. Salles, D. de Jong, 2017, European journal of cancer.

Chemiluminescence: a test for predicting hematopoietic recovery after autologous or allogeneic bone marrow transplantation

M. Macro, X. Troussard, O. Reman, 1999, European journal of haematology.

Dasatinib (Sprycel®) and Low Intensity Chemotherapy for First-Line Treatment in Patients with De Novo Philadelphia Positive ALL Aged 55 and Over: Final Results of the EWALL-Ph-01 Study

J. Cayuela, H. Dombret, A. Delannoy, 2012 .

THE LONG-TERM OUTCOME OF ELDERLY PATIENTS WITH PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PH plus ALL) IN THE IMATINIB ERA

H. Dombret, A. Delannoy, M. Béné, 2009 .

Prognostic Impact of Bone Marrow B Lymphocyte Precursors (hematogones) Detection in 95 Acute Lymphoblastic Leukemia Cases

P. Chevallier, O. Reman, R. Garand, 2012 .

A Restrictive Strategy Reduces the Number of Transfused Packed Red Blood Cells in Allograft Recipients

O. Reman, A. Gac, J. Mear, 2014 .

Long-term results and competing risk analysis of the H89 trial in patients with advanced-stage Hodgkin lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte (GELA).

O. Casasnovas, C. Gisselbrecht, N. Mounier, 2006, Blood.

Skin manifestations in CD4+, CD56+ malignancies.

T. Petrella, M. Macro, X. Troussard, 2003, EJD. European journal of dermatology.

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) In Adults With Philadelphia Chromosome (Ph)-Negative Acute Lymphoblastic Leukemia (ALL): Results From The Group For Research On Adult ALL (GRAALL)

H. Dombret, P. Chevallier, D. Blaise, 2013 .

Unstable alpha‐chain hemoglobin variants with factitious beta‐thalassemia biosynthetic ratio: Hb questembert (α131[H14] Ser→Pro) and Hb Caen (α132[H15] Val→Gly)

D. Labie, O. Reman, H. Wajcman, 1993 .

Semi-ambulatory autologous peripheral blood SCT in 79 patients with multiple myeloma

M. Macro, O. Reman, Q. Cabrera, 2013, Bone Marrow Transplantation.

Arsenic Trioxide (AS2O3) Therapy for Relapsed Acute Promyelocytic Leukemia (APL): Comparison with a Historic Control Combining All-Trans Retinoic Acid (ATRA) Plus Intensive Chemotherapy.

A. Stamatoullas, M. Bernard, P. Fenaux, 2005 .

Leopard spot retinopathy: an early clinical marker of leukaemia recurrence?

O. Reman, M. Robert, C. Faure, 2008, Annals of Hematology.

L-Asparaginase-Loaded Red Blood Cells Combined with Standard EWALL Chemotherapy in Older Patients with Newly Diagnosed Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia (Ph- ALL): First Results of the GRASPALL/GRAALL-SA2-2008 Study

H. Dombret, S. Leprêtre, P. Chevallier, 2011 .

Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome – positive acute lymphoblastic leukemia : results of the GRAAPH-2003 study

J. Cayuela, H. Dombret, E. Macintyre, 2007 .

Predictive factors for a single successful cytapheresis session during the first mobilisation.

M. Macro, O. Reman, J. Parienti, 2014, Leukemia research.

Childhood leukemia incidence in the vicinity of La Hague nuclear-waste reprocessing facility (France)

Jean-François Viel, J. Viel, O. Reman, 1993, Cancer Causes & Control.

A retrospective series of gut aspergillosis in haematology patients.

A. Vekhoff, A. Thiébaut, O. Reman, 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Is ARAC Required in the Treatment of Newly Diagnosed APL? Results of a Randomized Trial (APL 2000).

H. Dombret, A. Stamatoullas, A. Vekhoff, 2004 .

[Chronic lymphoid leukemia with iliac osteolysis].

X. Troussard, O. Reman, M. Leporrier, 1990, Revue du rhumatisme et des maladies osteo-articulaires.

Update of the French LGL Proliferation Registry : Report of 229 Cases

O. Reman, J. Rey, O. Tournilhac, 2009 .

Outcome of Treatment after First Relapse in Adults Patients with Acute Lymphoblastic Leukemia (ALL) Initially Treated by the LALA-94 Trial.

A. Stamatoullas, A. Delannoy, J. Gabert, 2006 .

Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome – positive acute lymphoblastic leukemia : results of the GRAAPH-2003 study

J. Cayuela, H. Dombret, E. Macintyre, 2007 .

The favorable impact of CEBPA mutations in patients with acute myeloid leukemia is only observed in the absence of associated cytogenetic abnormalities and FLT3 internal duplication.

H. Dombret, C. Preudhomme, C. Gardin, 2009, Blood.